Showing 1-7 of 7 results
-
Prayut defends govt virus crisis handling
News, Akarach Sattaburuth, Published on 03/09/2021
» Prime Minister Prayut Chan-o-cha defended the government's handling of the Covid-19 crisis and vaccination policy on the third day of the censure debate on Thursday.
-
PM hints at shortening, lifting night curfew
Akarach Sattaburuth, Published on 01/09/2021
» The night curfew in dark-red zones may be shortened or lifted, depending on the Covid-19 situation, Prime Minister Prayut Chan-o-cha said on Wednesday.
-
Govt denies jab purchase graft
News, Akarach Sattaburuth, Published on 01/09/2021
» The government has defended itself against accusations of corruption in its procurement of Covid-19 vaccines, saying the allegation that it pocketed change from previous Sinovac purchases was totally untrue and that its spending was above board and transparent.
-
Meeting sets dates for censure debate
News, Akarach Sattaburuth, Published on 27/08/2021
» The censure debate will take place over four days from Aug 31 to Sept 3 with the vote to be cast on Sept 4, Palang Pracharath MP for Bangkok Patcharin Sumsiripong said on Thursday.
-
MFA claims spending list 'not lavish'
News, Akarach Sattaburuth, Published on 21/08/2021
» The Ministry of Foreign Affairs (MFA) has defended its spending plans after they came under heavy fire from the Move Forward Party during this week's 2022 budget debate.
-
Govt faces censure over Covid crisis
News, Akarach Sattaburuth, Published on 12/08/2021
» The opposition will file a no-confidence motion against the government next Monday targeting Prime Minister Prayut Chan-o-cha and Public Health Minister Anutin Charnvirakul over the Covid-19 crisis.
-
Pheu Thai lambastes DDC leadership over Astra deal
News, Akarach Sattaburuth, Published on 21/07/2021
» The main opposition Pheu Thai Party on Tuesday demanded Public Health Minister Anutin Charnvirakul replace the director-general of the Department of Disease Control (DDC) over failures to reveal the contents of the contract for procuring the AstraZeneca vaccine and alleged faults during the management of vaccine allocation.
Your recent history
-
Recently searched
-
Recently viewed links